PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-3478

  1. 478 Posts.
    lightbulb Created with Sketch. 130
    You read that and it amazes me how a drug gets rubber stamped with very little analysis.
    How do the FDA know that type of pentosan is safe and can be produced consistently?
    Was is proven to be identical to benes product the only approved pentosan of any description?
    We had months and months of hold ups due to one rats adrenal gland and this gets through to treat horses so easily.
    Why this particular pentosan and not others?
    It doesn't add up just like who makes it.
    Its nearly impossible to find information on the drug owner or manufacturer,that seems to be done on purpose to hide any links to anybody.
    Something doesn't seem like its been disclosed because its just wierd
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
31.0¢
Change
0.035(12.7%)
Mkt cap ! $108.4M
Open High Low Value Volume
27.5¢ 31.0¢ 27.5¢ $108.9K 371.2K

Buyers (Bids)

No. Vol. Price($)
1 1000 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 17420 5
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.